The Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome Coronavirus-2 (SARS CoV-2) infection attacking mainly on the immune system of a body. It is a potentially fatal disease that is of public health and economy concern globally. In December 2019, COVID-19 outbreak occurred in Wuhan city, Hubei Province, China furthermore spread worldwide. Research is underway in many countries to develop effective vaccines and drugs for the COVID-19. In Ayurveda, Acharya Charaka explained the concept of an epidemic condition in Janapadodhwans Adhayay and combating of these diseases is to be done by Panchakarma (five procedures of purification), Rasayana Chikitsa (immune-modulators therapy) and Sadvritta (good conduct). Rasayan dravyas (immuno modulators drugs) of Ayurveda can be used for health promotion, immune-modulation, prevention and reduce disease burden from COVID-19. Drugs such as Ashwagandha (Withania somnifera (L.) Dunal), Guduchi (Tinospora cordifoloia (Willd.) Miers), Amalaki (Phyllanthus emblica L.), Mulethi (Glycyrrhiza glabra L.), Shatavari (Asparagus racemosus Willd), Chireta (Andrographis paniculata (Burm.f.) Nees), Tulsi (Ocimum sanctum L.) Punarnava (Boerhaavia diffusa L.) and Pippali ((Piper longum L.) For symptom management of COVID-19 like illness Agastya Haritaki, Anutaila, AYUSH–64 can be used. Scientific research on these drugs may reveal the new approach for the prevention and management of COVID-19. The main aim of this article is to review research which has already conducted and currently being carried out on the herbal plant for their immunomodulation property which have a possible application in the prevention and treatment of COVID-19.
Background: Prakriti has important role in prevention, diagnosis, treatment of disease and forecast of future disorders. Infants are more prone to develop various health problems like infections, due to poor immune system. This study shows relation between infantile age morbidity and their Prakriti (physical constitution) in present scenario. Material and Methods: For this longitudinal study 100 infants were registered for Prakriti assessment and their relationship with incidence of diseases. Performa for Prakriti assessment in infants was developed by Department of Kaumarbhritya/Balroga and Department of Kriya Sharira. This study was conducted in Kaumarbhritya OPD, SS Hospital, Banaras Hindu University (BHU). Observation and Result: In the present study, rate of morbidity in infantile age was found maximum in Vata Prakriti (6.6 episodes/infant/year) and minimum in Kapha Prakriti (1.54 episodes/infant/year). Incidence of morbidity was 2.41 episodes/infant/year. The commonest morbidities were respiratory tract infections (40.66%) and diarrhea (30.29%). Respiratory tract infection is most common morbidity in Vata Prakriti (33.3%), Kapha Prakriti (73.5%), Vata-Pitta Prakriti (48.1%) and Vata Kapha Prakriti (53.3%) infants. Diarrhea was the most common morbidity in Pitta Prakriti (32.2%) and Pitta-Kapha Prakriti (50.0%) infants. Discussion and Conclusion: Rate of morbidity was found more in Vata Prakriti and less in Kapha Prakriti infants which justifies the concept of Ayurveda that feature of Vata Prakriti is Shighravikara and Kapha Prakriti have Ashighravikara. Vata and Kapha Prakriti infants mostly suffer from respiratory tract infection and Pitta Prakriti infants mostly suffer from diarrhea. In present study incidence of morbidity was 2.41 episodes/infant/year and most common morbidity was respiratory tract infection and diarrhea.
The first description of Jalaukavacharana (leech therapy) is available in Sushruta Samhita written in 800 B.C. Recently, many pieces of research have proved that leech saliva has a variety of bioactive compounds including anti-thrombin (Hirudin, bufrudin), antiplatelet (calin), factor Xa inhibitors, antibacterial and other property. The main objective of the present article is to explore the procedures of leech therapy and research works done over a few decades on the application of leech therapy in different medico-surgical diseases. The procedure of leech therapy is documented from authors' observations and information, and its application in different diseases is gathered from various published works of the last ten years. Many clinical pieces of research show that leech therapy is beneficial in various medico-surgical diseases. A total of eight publications were included in the final selection after systematic analysis. Leech therapy or Jalaukavacharan is an ancient Ayurvedic bloodletting technique that has the great potential to manage many inflammatory, ischemic, and infectious diseases. Leech’s saliva contains many biologically and pharmacologically active compounds that exert anticoagulant, antiplatelet, anti-inflammatory, and anti-edema effects in the host's body. Arthritis, venous congestion, vascular diseases, abscess, ischemic heart disease, etc. can be successfully managed by leech therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.